Most aging countries in the world are experiencing the problems of insufficient motivation for technological innovation and excessive medical costs. This research thus utilizes medical patent applications and medical innovation efficiency to measure medical innovation for 41 countries covering...

We study how innovative firms manage their innovation portfolios after filing for Chapter 11 reorganization using three decades of data. We find that they sell off core (i.e., technologically critical and valuable), rather than peripheral, patents in bankruptcy. The selling pattern is driven...

Using panel data on U.S. public firms, we document a positive effect of board independence on corporate innovation. This effect is concentrated in firms that are larger in size, in the non-technical industries, facing less product market competition, and using more debt, where managers are more...